Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$25.55 – $35.06
58% from low
Exchange
ARCX
ETF
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|
| Revenue | $6.3K | −$5.0K | $1.3M | −$610.0K |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $6.3K | −$5.0K | $1.3M | −$610.0K |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $0 | $0 | $0 | $0 |
| Operating income | $6.3K | −$5.0K | $1.1M | $93.8K |
| EBITDA | $6.3K | $668 | $1.1M | $93.8K |
| Net income | $0 | $0 | $1.1M | $93.8K |
| Net margin | 0.0% | 0.0% | 85.5% | -15.4% |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CMDTPIMCO Commodity Strategy Active Exchange-Traded Fund | $30.50 | -0.55% | $814M | — |
| EYLDCambria Emerging Shareholder Yield ETF | $45.42 | -0.04% | $818M | — |
| FIIGFirst Trust Intermediate Duration Investment Grade Corporate ETF | $20.79 | +0.07% | $681M | — |
| HCMTDirexion HCM Tactical Enhanced US ETF | $40.89 | +3.78% | $652M | — |
| IHEiShares U.S. Pharmaceuticals ETF |
No company description on file.
No one on the platform currently holds CMDT.
No tracked institution reports a position in CMDT as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-01 | $0.1900 | 2026-04-03 |
| 2025-12-31 | $0.2200 | 2026-01-05 |
| 2025-10-01 | $0.2100 | 2025-10-03 |
| 2025-07-01 | $0.2100 | 2025-07-03 |
| 2025-04-01 | $0.2000 | 2025-04-03 |
| 2024-12-31 | $0.9300 | 2025-01-03 |
| 2024-10-01 | $0.7600 | 2024-10-03 |
| 2024-07-01 | $0.2600 | 2024-07-03 |
| 2024-04-01 | $0.2700 | 2024-04-04 |
| 2023-12-28 | $0.3100 | 2024-01-03 |
No one on the platform has traded CMDT yet.
| $100.13 |
| +1.01% |
| $776M |
| — |
| LSGRNatixis Loomis Sayles Focused Growth ETF | $42.05 | +2.06% | $667M | — |
| SFYSoFi Select 500 ETF | $147.20 | +1.67% | $678M | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-11 |
| $0.0323 |
| 2023-12-14 |
| 2023-10-02 | $0.3210 | 2023-10-05 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.